Professor James Galloway
Professor of Rheumatology
- Arthritis UK Endowed Chair in Rheumatology
- Deputy Head of the Centre for Rheumatic Diseases (CRD)
- Senior Director for the GKT School of Medical Education
Biography
Professor James Galloway is Arthritis UK Professor of Rheumatology at King’s College London and an Honorary Consultant Rheumatologist at King’s College Hospital NHS Foundation Trust. He serves as Senior Director for the MBBS Programme within the GKT School of Medical Education, providing strategic leadership for the undergraduate medical degree and supporting the development of curriculum, assessment and programme delivery across the medical school.
He is also Programme Director for the PGCert in Applied Research Methods, part of the Integrated Academic Training programme, where he supports clinical trainees in developing research skills and academic careers.
Professor Galloway leads a research group at the Centre for Rheumatic Diseases focused on big data analytics, population health research, pharmacovigilance and healthcare delivery research in immune-mediated inflammatory diseases. His work uses large-scale routinely collected health data to study disease epidemiology, treatment patterns and long-term outcomes, with a particular focus on the safety and effectiveness of immunomodulatory therapies in real-world clinical practice.
He holds several national and international leadership roles, including contributing to clinical guidelines for the British Society for Rheumatology and EULAR, and serving as methodology lead for the National Early Inflammatory Arthritis Audit. He is also Chief Medical Advisor to the National Rheumatoid Arthritis Society (NRAS).
Professor Galloway is Deputy Editor of Rheumatology and has published widely on inflammatory rheumatic diseases, including studies on treatment outcomes, drug safety and health inequalities.
Teaching
- MBBS Senior Director
- PG Cert in Applied Research Methods Programme Director
Research
King’s Health Programmes Attainment Gaps Research Group
Providing culturally appropriate care for all is core to health equality and patient-centred care.
Clinical Diagnostics Development Unit (CDDU)
The CDDU ethos is to harmonise all methods used within the labs for the processing of clinical samples.
Galloway & Norton Group
The Galloway & Norton Group is a Clinical Epidemiology and Trials research team focused on immune‑mediated rheumatic diseases.
News
Stricter approval process reduces prescribing of anti-seizure drug that can cause birth defects
The introduction of a stricter approval process for prescribing an anti-seizure drug that can cause birth defects when taken during pregnancy has been...
Professor James Galloway appointed as Versus Arthritis Endowed Chair
Professor James Galloway from the School of Immunology & Microbial Sciences at King’s College London has been announced as the new Versus Arthritis Endowed...
Asian and older rheumatoid arthritis sufferers 50% less likely to receive targeted treatment
Asian patients are half as likely to be started on biologic drugs for rheumatoid arthritis than White patients, new research has shown.
King's College London announced winner of the Government's AI Fairness Innovation Challenge
A project led by Dr Zina Ibrahim, Senior Lecturer in Artificial Intelligence in Medicine at the Institute of Psychiatry, Psychology & Neuroscience, has won...
Developing Translational Research Capabilities in the School of Immunology & Microbial Sciences
Researchers from the School of Immunology & Microbial Sciences have been awarded funding through King's Health Partners Essentials for Translational Medical...
One in five patients with rheumatoid arthritis were undiagnosed during the pandemic
The number of new diagnoses of rheumatoid arthritis fell by 20% in the first year of the COVID-19 pandemic, new research suggests.
Higher rate of COVID-19 death before vaccination linked to certain common inflammatory immune conditions
People with inflammatory immune conditions that affect their skin, bowel, and joints have been linked to a greater risk of being hospitalised and death from...
Just one in three people with gout prescribed preventative medication
Just one in three patients with gout in the UK received preventative medication within a year of diagnosis, new research has found.
National trial launched to find Covid-19 treatment
A new trial to prevent organ failure and death in Covid-19 patients is being launched and led by clinicians and scientists at King’s and in Cambridge.
Events
Professor Sam Norton - Inaugural Lecture
Join us in celebrating Professor Norton's inaugural lecture on 'Sancte et Sapienter (Sort Of): Making mistakes in the service of science.'
Please note: this event has passed.
Inaugural Lectures: Professors James Galloway & Anita Grigoriadis
Inspiring talks from two of our new professors about rheumatic diseases epidemiology and breast cancer research
Please note: this event has passed.
Research
King’s Health Programmes Attainment Gaps Research Group
Providing culturally appropriate care for all is core to health equality and patient-centred care.
Clinical Diagnostics Development Unit (CDDU)
The CDDU ethos is to harmonise all methods used within the labs for the processing of clinical samples.
Galloway & Norton Group
The Galloway & Norton Group is a Clinical Epidemiology and Trials research team focused on immune‑mediated rheumatic diseases.
News
Stricter approval process reduces prescribing of anti-seizure drug that can cause birth defects
The introduction of a stricter approval process for prescribing an anti-seizure drug that can cause birth defects when taken during pregnancy has been...
Professor James Galloway appointed as Versus Arthritis Endowed Chair
Professor James Galloway from the School of Immunology & Microbial Sciences at King’s College London has been announced as the new Versus Arthritis Endowed...
Asian and older rheumatoid arthritis sufferers 50% less likely to receive targeted treatment
Asian patients are half as likely to be started on biologic drugs for rheumatoid arthritis than White patients, new research has shown.
King's College London announced winner of the Government's AI Fairness Innovation Challenge
A project led by Dr Zina Ibrahim, Senior Lecturer in Artificial Intelligence in Medicine at the Institute of Psychiatry, Psychology & Neuroscience, has won...
Developing Translational Research Capabilities in the School of Immunology & Microbial Sciences
Researchers from the School of Immunology & Microbial Sciences have been awarded funding through King's Health Partners Essentials for Translational Medical...
One in five patients with rheumatoid arthritis were undiagnosed during the pandemic
The number of new diagnoses of rheumatoid arthritis fell by 20% in the first year of the COVID-19 pandemic, new research suggests.
Higher rate of COVID-19 death before vaccination linked to certain common inflammatory immune conditions
People with inflammatory immune conditions that affect their skin, bowel, and joints have been linked to a greater risk of being hospitalised and death from...
Just one in three people with gout prescribed preventative medication
Just one in three patients with gout in the UK received preventative medication within a year of diagnosis, new research has found.
National trial launched to find Covid-19 treatment
A new trial to prevent organ failure and death in Covid-19 patients is being launched and led by clinicians and scientists at King’s and in Cambridge.
Events
Professor Sam Norton - Inaugural Lecture
Join us in celebrating Professor Norton's inaugural lecture on 'Sancte et Sapienter (Sort Of): Making mistakes in the service of science.'
Please note: this event has passed.
Inaugural Lectures: Professors James Galloway & Anita Grigoriadis
Inspiring talks from two of our new professors about rheumatic diseases epidemiology and breast cancer research
Please note: this event has passed.